Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

about

Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.

P2860

Q47129380-CA104AAC-A9F5-4314-BE21-C3CAF029B74E

P2860

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

Item

http://www.wikidata.org/entity/Q36390358

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

@ast

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

@en

type

Item

label

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

@ast

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

@en

prefLabel

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

@ast

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

@en

P1476

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

@en

P2093

Eun-Sil Yu

http://www.w3.org/2001/XMLSchema#string

Hyo-Ju Lee

http://www.w3.org/2001/XMLSchema#string

Hyun-Ji Choi

http://www.w3.org/2001/XMLSchema#string

Hyun-Kyu Park

http://www.w3.org/2001/XMLSchema#string

Ja-June Jang

http://www.w3.org/2001/XMLSchema#string

Jae-Eun Ryu

http://www.w3.org/2001/XMLSchema#string

Minsun Chang

http://www.w3.org/2001/XMLSchema#string

Sungwoong Jang

http://www.w3.org/2001/XMLSchema#string

Woo-Chan Son

http://www.w3.org/2001/XMLSchema#string

Woori Jo

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: An Update

Role of AMP-activated protein kinase in mechanism of metformin action

Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Primary prevention of hepatocellular carcinoma in developing countries.

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

Global patterns of cancer incidence and mortality rates and trends.

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.

Oval cell-mediated liver regeneration: Role of cytokines and growth factors.

P304

146-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2015.4513

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26548419

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

4686101

http://www.w3.org/2001/XMLSchema#string

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

about

P2860

P2860

Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932